Skip to main content
 

Oliver Weiss Piepenstock

Oliver Weiss Piepenstock

Trained as a financial economist (M.Sc. at Copenhagen Business School), Oliver started in investment banking before switching to healthcare and building his first startup Mecasa. Inspired by the purpose of making a difference in people’s lives, Oliver co-founded Noah Labs in 2021, where he serves as CEO. Noah Labs develops voice-based digital biomarkers for the early detection of decompensated Heart Failure and currently runs trials at the Mayo Clinic and several centers in the EU.

More News

  • PharmaSmart Joins American Heart Association Innovators’ Network to Advance Evidence-Based Chronic Disease Screening and Community Health Technology & Innovation

  • AI Agents: From Chatbots to Patient Prescribing

  • How AI tools can enable more proactive care